Best GLP-1 Pill for Weight Loss in 2026: The Honest Buyer's Guide
Published:
The best GLP-1 pill for weight loss in 2026 is the Wegovy® pill (oral semaglutide) for most adults — it produces the highest weight loss in trials and is the only oral GLP-1 with an FDA cardiovascular protection label. The better pick is Foundayo™ (orforglipron) if you can't fast for 30 minutes every morning, because it's the only GLP-1 pill you can take with food, with coffee, at any time of day. These are the only two GLP-1 pills the FDA has approved for chronic weight management in 2026.
| Your situation | Best pill | Best provider |
|---|---|---|
| You want the highest trial weight loss and can fast 30 min in the morning | Wegovy® pill | Ro |
| You want the simplest daily routine — no fasting, no timing | Foundayo™ | Ro |
| You have heart disease + obesity and want CV protection on the label | Wegovy® pill | Ro |
| You travel a lot, work shifts, or have chaotic mornings | Foundayo™ | Ro |
| You want a video visit with a doctor of your choice and lab work included | Either pill | Sesame Care |
| You already have a prescriber and just want fulfillment | Either pill | NovoCare (Wegovy pill) or LillyDirect (Foundayo) |
| You see “GLP-1 drops” or “GLP-1 lozenges” online | Read the compounded section first | — |
Decision Resolution Point #1
If the FDA-approved pill path fits what you're looking for, check current Wegovy pill and Foundayo eligibility on Ro. Coverage check is free — Ro can check benefits before any medication is billed.
Wegovy Pill vs Foundayo: Which GLP-1 Pill Should You Choose?
Wegovy pill produces more weight loss in trials (13.6%–16.6% vs 11.1%–12.4%) and has the FDA cardiovascular outcomes label that Foundayo lacks. Foundayo is the only GLP-1 pill that doesn't require a 30-minute morning fast — you can take it any time of day, with or without food. Both cost $149/month at the lowest dose and rise to $299/month at maintenance. Both can drop to as low as $25/month for eligible commercially insured patients using the manufacturer savings offer.
| Feature | Wegovy® pill | Foundayo™ |
|---|---|---|
| Active ingredient | Semaglutide (peptide) | Orforglipron (small molecule, non-peptide) |
| Maker | Novo Nordisk | Eli Lilly |
| FDA approval (weight loss) | December 22, 2025 | April 1, 2026 |
| Trial weight loss (highest dose) | 13.6% (treatment policy) / 16.6% (full adherence) — OASIS 4 | 11.1% (treatment policy) / 12.4% (full adherence) — ATTAIN-1 |
| Cardiovascular outcomes label | Yes ✔ | No |
| Dose schedule | 30-day steps: 1.5 → 4 → 9 → 25 mg | 30-day steps: 0.8 → 2.5 → 5.5 → 9 → 14.5 → 17.2 mg |
| Food/water/timing rules | Empty stomach, ≤4 oz water, fast 30 min | None — any time, with or without food |
| Cash price (Ro / NovoCare / LillyDirect) | $149/mo lowest doses; $299/mo at 9 mg and 25 mg | $149 → $199 → $299/mo through escalation; $299/mo at high doses with 45-day refill, otherwise $349 |
| With eligible commercial insurance + savings offer | As low as $25/mo | As low as $25/mo |
| Best for | Maximum weight loss, CV protection, structured morning | Daily simplicity, shift workers, travelers, needle-averse new starters |
| Biggest drawback | The 30-minute morning fast is real and hard to keep | Newer to market; no CV outcomes label yet |
How Many GLP-1 Pills Are FDA-Approved for Weight Loss in 2026?
Exactly two. The Wegovy pill (oral semaglutide 25 mg, FDA-approved December 22, 2025) and Foundayo (orforglipron, FDA-approved April 1, 2026) are the only GLP-1 pills the FDA has approved for chronic weight management. Rybelsus is also a GLP-1 pill, but it's approved only for type 2 diabetes. Compounded oral GLP-1 drops, lozenges, and OTC “GLP-1 booster” supplements are not FDA-approved and are not the same drugs.
FDA-Approved #1
Wegovy® pill
Oral semaglutide 25 mg — FDA approved December 22, 2025. Made by Novo Nordisk. Same company behind injectable Wegovy and Ozempic.
Approved for chronic weight management in adults
FDA-Approved #2
Foundayo™ (orforglipron)
Small-molecule non-peptide GLP-1 pill — FDA approved April 1, 2026. Made by Eli Lilly. Fastest new drug approval since 2002, per FDA Commissioner's National Priority Voucher pilot.
Approved for chronic weight management in adults
What about Rybelsus and Ozempic tablets?
Rybelsus is also oral semaglutide (since 2019), but the FDA approved Rybelsus only for type 2 diabetes — not for weight loss. The dose ceiling is 14 mg (vs 25 mg for the Wegovy pill). In April 2026, Novo introduced Ozempic tablets for type 2 diabetes in 1.5 mg, 4 mg, and 9 mg strengths — also approved for diabetes, not weight loss. If your goal is weight loss and you want a pill, the Wegovy pill or Foundayo are better aligned.
What “GLP-1 pill” does NOT mean
A real GLP-1 pill for weight loss has a brand name (Wegovy pill or Foundayo), an FDA approval, and a prescription requirement. Everything else needs more scrutiny.
Is Wegovy® Pill the Best GLP-1 Pill for Maximum Weight Loss?
Yes — the Wegovy pill produces the highest weight loss in trials of any FDA-approved GLP-1 pill and is the only one with an FDA cardiovascular protection label. Average weight loss was 13.6% over 64 weeks in OASIS 4 (16.6% with full adherence). Cash price on Ro: $149/month for starter doses, $299/month at maintenance.
What the trial actually showed
In the OASIS 4 trial, 307 adults with obesity or overweight (no diabetes) took oral semaglutide 25 mg or placebo for 64 weeks:
16.6%
Average weight loss for adherent participants
13.6%
Average across all participants (including drop-outs)
34%
Of adherent participants lost 20% or more of body weight
For someone starting at 220 pounds, the average translates to roughly 30–37 pounds lost over 14 months. Placebo group lost about 2–3%.
How to take it — this is the catch
The Wegovy pill must be taken on an empty stomach, with no more than 4 ounces of water, and you cannot eat, drink anything else, or take other oral medications for 30 minutes after. Then you can have your coffee, breakfast, and other pills.
If your morning is “wake up, coffee, kids, out the door” — you're going to miss this pill more than you think.
The dose schedule (per FDA label)
| Period | Dose | Cash price (Ro / NovoCare) | With eligible insurance + savings offer |
|---|---|---|---|
| Days 1–30 | 1.5 mg once daily | $149/mo | As low as $25/mo |
| Days 31–60 | 4 mg once daily | $149/mo (through Aug 31, 2026; then $199/mo) | As low as $25/mo |
| Days 61–90 | 9 mg once daily | $299/mo | $249/mo (12-mo subscription) | As low as $25/mo |
| Day 91 onward | 25 mg once daily (maintenance) | $299/mo | $249/mo (12-mo subscription) | As low as $25/mo |
The 12-month subscription for self-pay patients applies to the 9 mg and 25 mg doses only. Saves up to $600/year on the pill. Sources: NovoCare pharmacy; Ro pricing page; Novo Nordisk press release April 1, 2026. Verified May 8, 2026.
Wegovy pill is the right fit if you…
- Have eligible commercial insurance that covers Wegovy (as low as $25/mo)
- Want the highest mean weight loss available in pill form
- Have established cardiovascular disease + obesity (only oral GLP-1 with CV protection label)
- Can reliably do the 30-minute morning fast every day
- Are switching from injectable Wegovy and want same active ingredient in pill form
Wegovy pill is NOT the right fit if you…
- Travel for work, do shift work, or have unpredictable mornings
- Have a personal or family history of medullary thyroid carcinoma or MEN2 (boxed warning)
- Need a GLP-1 for type 2 diabetes — Wegovy pill is approved only for weight loss
Decision Resolution Point #2
If the Wegovy pill matches your situation, check eligibility on Ro. Ro charges the same medication price as NovoCare and LillyDirect, plus a Ro Body membership ($39 first month, then as low as $74/month with annual prepay or $149/month monthly). Insurance concierge included.
Check Wegovy pill eligibility on Ro → (sponsored affiliate link, opens in a new tab)Is Foundayo™ the Best GLP-1 Pill If You Want No Fasting Rules?
Yes — Foundayo is the only GLP-1 pill you can take any time of day, with or without food, with or without water. FDA-approved April 1, 2026. Highest-dose weight loss was 11.1% at 72 weeks in the FDA label's Trial 1 (12.4% with full adherence). Cash price on Ro: $149–$299/month with the manufacturer offer.
What the trial actually showed
12.4%
Mean weight loss with full adherence (ATTAIN-1, 72 weeks)
11.1%
Mean weight loss across all participants (treatment policy)
27.3 lbs
Average pounds lost at the highest dose (Lilly launch data)
Trial 2 (adults with type 2 diabetes) showed 9.6% vs 2.5% with placebo. Foundayo also reduced waist circumference, non-HDL cholesterol, triglycerides, and systolic blood pressure across all dose levels.
How to take it — the simple part
Foundayo can be taken any time of day, with or without food, with or without water. With breakfast. With coffee. While you're getting the kids ready or driving to work.
This is unique among GLP-1 pills. Foundayo is a small-molecule, non-peptide drug — its molecular structure holds up in your stomach better than oral semaglutide does, so it doesn't need a fasting window to absorb properly.
The dose schedule (per FDA label)
| Period | Dose | Cash price (Ro / LillyDirect with offer) | With eligible insurance + savings card |
|---|---|---|---|
| Days 1–30 | 0.8 mg | $149/mo | As low as $25/mo |
| Days 31–60 | 2.5 mg | $199/mo | As low as $25/mo |
| Days 61–90 | 5.5 mg | $299/mo | As low as $25/mo |
| Then escalate | 9 mg | $299/mo | As low as $25/mo |
| Then escalate | 14.5 mg | $299/mo (45-day refill) or $349/mo | As low as $25/mo |
| Maintenance | 17.2 mg | $299/mo (45-day refill) or $349/mo | As low as $25/mo |
Medicare Part D coverage for Foundayo is expected to start at $50/mo on July 1, 2026 via the GLP-1 Bridge program. Sources: LillyDirect; Ro pricing page. Verified May 8, 2026.
Foundayo is the right fit if you…
- Have a morning routine that can’t accommodate a 30-minute fast
- Travel often or work shifts
- Want the simplest possible daily pill schedule
- Are needle-phobic and brand new to GLP-1 therapy
- Have eligible commercial insurance (as low as $25/mo)
- Are switching from an injectable to a pill for maintenance
Foundayo is NOT the right fit if you…
- Have established heart disease and want CV-protection labeling — the Wegovy pill has it; Foundayo doesn’t yet
- Take combined oral birth control pills and aren’t willing to use backup contraception
- Have a personal or family history of medullary thyroid carcinoma or MEN2 (boxed warning)
- Need to combine with another GLP-1 — not allowed for either pill
Decision Resolution Point #3
If your morning won't accommodate a 30-minute fast, Foundayo solves that problem. Ro added Foundayo on April 9, 2026 — same $149 starter pricing as LillyDirect, plus telehealth access nationwide.
What You'll REALLY Pay Over 12 Months (Not Just the First Month)
Almost every article quotes the $149 starter price. That's accurate for the lowest dose only. Realistic 12-month medication cost on Ro at cash pricing is about $3,288 for the Wegovy pill and $3,338 for Foundayo with the manufacturer offer. With eligible commercial insurance and the savings card, both can drop to about $300 a year. Add $888 per year for the Ro Body membership at the annual prepay rate ($74/mo).
| Month | Wegovy pill cash | Wegovy + insurance savings | Wegovy 12-mo subscription (9 mg+ only) | Foundayo cash (with offer) | Foundayo + insurance savings |
|---|---|---|---|---|---|
| Month 1 | $149 (1.5 mg) | $25 | $149 (1.5 mg) | $149 (0.8 mg) | $25 |
| Month 2 | $149 (4 mg) | $25 | $149 (4 mg) | $199 (2.5 mg) | $25 |
| Month 3 | $299 (9 mg) | $25 | $249 (9 mg, subscription) | $299 (5.5 mg) | $25 |
| Month 4 | $299 (25 mg) | $25 | $249 | $299 (9 mg) | $25 |
| Month 5 | $299 | $25 | $249 | $299 (14.5 mg) | $25 |
| Months 6–12 | $299/mo | $25/mo | $249/mo | $299/mo (17.2 mg, with 45-day refill) | $25/mo |
| 12-month medication total | $3,288 | $300 | $2,788 | $3,338 (with offer) / $3,738 (if 45-day missed) | $300 |
| Plus Ro Body annual ($74/mo) | +$888 | +$888 | +$888 | +$888 | +$888 |
| Grand total (Ro path) | $4,176 | $1,188 | $3,676 | $4,226 (with offer) / $4,626 (if missed) | $1,188 |
Every row verified against FDA prescribing labels for both medications, NovoCare pharmacy pricing, Eli Lilly's Foundayo pricing terms, Ro's published pricing pages, and the Wegovy 12-month subscription terms (Novo Nordisk press release, April 1, 2026). Verified May 8, 2026.
If insurance covers your pill, you’ll pay roughly $300 a year for medication
Plus the Ro Body membership if you go through them. About $25/mo for medication, $74/mo for the program. Total: about $1,200/year.
If you’re paying cash, you’re looking at roughly $4,200 a year all in
About $350/mo averaged across the year — significantly more than the $149 advertised price.
The Wegovy 12-month subscription saves about $500 over straight cash if you’re committed for the year
Foundayo doesn’t have an equivalent subscription program yet.
Insurance doesn’t always pay $25/mo
“As low as $25/mo” applies to eligible commercially insured patients using the manufacturer savings offer. Patients on Medicare, Medicaid, or other government plans are typically excluded from the $25 pricing.
Three ways to lower your real cost
- 1Run insurance first: Ro’s free GLP-1 Insurance Coverage Checker tells you in 60 seconds whether your commercial plan covers Wegovy or Foundayo. This is the highest-leverage move and costs nothing.
- 2Use HSA/FSA dollars: Prescription GLP-1 medication is generally HSA/FSA eligible. If you have one of these accounts, you’re effectively paying with pre-tax dollars.
- 3If paying cash, use the Wegovy 12-month subscription: For the high doses. It locks 9 mg and 25 mg at $249/mo and saves up to $600 a year vs the cash list price.
Decision Resolution Point #4
Run your insurance through Ro's free coverage checker before paying cash. 60 seconds. No commitment. Coverage varies by plan, and Ro can check benefits before any medication is billed.
Check coverage on Ro → (sponsored affiliate link, opens in a new tab)Where to Get a GLP-1 Pill Online (Provider Comparison)
For most readers, Ro is the most efficient path because it carries both Foundayo and the Wegovy pill, posts dose-level pricing that matches LillyDirect/NovoCare/TrumpRx, and includes a free insurance concierge that handles prior authorization paperwork.
| Provider | Wegovy pill? | Foundayo? | Insurance support | Program fee | Notes |
|---|---|---|---|---|---|
| Ro (our pick) | Yes | Yes (since Apr 9, 2026) | Yes — free coverage checker + concierge handles prior auth | $39 first month, then $74/mo annual prepay or $149/mo monthly; medication billed separately | Broadest FDA-approved GLP-1 oral formulary on telehealth |
| Sesame Care | Yes | Yes | Provider can assist with PA; Sesame subscription not billed to insurance | Per-visit pricing or program plans | Video visits with provider choice; broader brand selection (also Mounjaro, Saxenda) |
| Hims | Yes | Yes (per current Hims listing) | Limited | Subscription | Male-coded brand; got Wegovy pill via Novo partnership March 2026 |
| Hers | Yes | Yes (per current Hers Foundayo page) | Limited | Subscription | Female-coded brand; same Novo partnership |
| LifeMD | Yes | Yes (announced April 10, 2026, via LillyDirect) | Limited | Membership | Original Wegovy pill launch partner |
| WeightWatchers | Yes | Yes (announced April 9, 2026, via WW Med+) | Limited | WW membership required | Bundled with WW behavior change program |
| NovoCare Pharmacy | Yes (direct) | No | None | None | Cheapest path for Wegovy pill if you already have a prescriber |
| LillyDirect | No | Yes (direct) | None | None | Cheapest path for Foundayo if you already have a prescriber |
Why Ro is our pick for FDA-approved GLP-1 pills
We're not pretending this isn't an affiliate recommendation — Ro is one of our partners. We disclosed that at the top and we'll repeat it here. Here's why we recommend Ro anyway, on the evidence:
Both pills under one roof
Other providers carry both pills too — Ro isn’t unique on that. But if your prescriber decides one isn’t right for you partway through treatment, Ro’s prescriber can switch without restarting paperwork at a different platform.
The insurance concierge is free
Ro runs your coverage check before you pay anything for medication, and the concierge handles prior authorization paperwork at no extra cost. For commercially insured patients whose plan covers the medication, this is the difference between $25 a month and $149+ a month.
Pricing matches the manufacturer
Ro states its medication prices match LillyDirect, NovoCare, and TrumpRx. You don’t pay a markup on the medication. The Ro Body membership is the only added cost.
National coverage
Ro operates in nearly every U.S. county, including 99% of primary care deserts. If your local doctor doesn’t prescribe GLP-1s, Ro is often the most realistic path.
When Sesame Care is the better pick
- You want a real video visit with a doctor of your choice, not an asynchronous form
- You want to choose your provider rather than be assigned one
- You want labs included
- You’re shopping multiple branded GLP-1s — Sesame carries Wegovy, Zepbound, Ozempic, Mounjaro, Foundayo, and Saxenda
- You’re a Costco member — Sesame offers Costco-member pricing on certain branded GLP-1s
The tradeoff: Sesame's program subscription isn't billed to insurance (your medication coverage may apply separately), and the per-visit cost can add up if you want frequent provider contact.
Compare Sesame Care → (sponsored affiliate link, opens in a new tab)The Pill Picker: Find Your Match in 60 Seconds
The right GLP-1 pill depends on five factors: insurance, your morning routine, your medical history, whether you're switching from an injection, and what matters more to you — maximum weight loss or simplest daily routine.
Answer 1 of 5 →
Q1: Do you have eligible commercial health insurance?
Quick guide — match yourself to an outcome without the interactive tool:
Outcome A: Wegovy® pill is your match
You can do the morning routine, you want maximum trial weight loss (13.6%–16.6%), and your situation supports it.
Outcome B: Foundayo™ is your match
Your schedule needs flexibility. No fasting, no timing rules. Slightly less weight loss in trials (11.1%–12.4%) but the simplest GLP-1 pill schedule on the market.
Outcome STOP: Speak to your doctor first
If you have a personal or family history of medullary thyroid carcinoma or MEN2. Both pills carry a boxed warning and are contraindicated for you.
Decision Resolution Point #6
Got your match? Start the consult on Ro. A licensed clinician reviews your intake and confirms whether a GLP-1 pill is clinically appropriate for you.
Start the consult on Ro → (sponsored affiliate link, opens in a new tab)Are GLP-1 Pills Really Less Effective Than the Shots?
Yes, slightly. The Wegovy pill produced 13.6%–16.6% mean weight loss vs about 15% for the Wegovy injection at 2.4 mg, and Foundayo produced 11.1%–12.4% vs ~21% for Zepbound (tirzepatide). The gap is real but not enormous. For most patients, taking the medication consistently every day matters at least as much as a 2–5 percentage point difference in trial efficacy.
| Medication | Form | Mean weight loss in trial (highest dose) | Trial |
|---|---|---|---|
| Zepbound 15 mg (tirzepatide) | Weekly injection | ~21% | SURMOUNT-1 |
| Wegovy 2.4 mg | Weekly injection | ~15% | STEP 1 |
| Wegovy pill 25 mg | Daily oral | 13.6% (treatment policy) / 16.6% (full adherence) | OASIS 4 |
| Foundayo 17.2 mg | Daily oral | 11.1% (treatment policy) / 12.4% (full adherence) | ATTAIN-1 |
When the pill is the right call anyway
- You’re needle-phobic and would skip injections altogether (a missed shot is 0% weight loss; an imperfect pill is some weight loss)
- You travel frequently — Wegovy injection requires refrigeration; pills don’t
- You’ve had injection-site issues
- You’re already at goal weight and switching from a shot to a pill for maintenance
- Your insurance covers a pill but not an injectable (or vice versa)
When the injection is the right call anyway
- You want the highest possible weight loss and a needle isn’t a dealbreaker
- You’d rather take medication once a week than once a day
- You have established cardiovascular disease — both Wegovy forms have CV outcomes labels
- Your insurance covers an injectable but not a pill
What About Compounded Oral GLP-1s, Drops, and OTC “GLP-1” Pills?
Compounded oral GLP-1 drops and lozenges are not FDA-approved and are not the same as Wegovy pill or Foundayo. The FDA has issued specific concerns about safety, dosing errors, and adverse events linked to unapproved compounded GLP-1 products. OTC “GLP-1 boosters” sold without a prescription are not GLP-1 medicine. If you're considering these, read this section first.
Compounded medications are made by licensed compounding pharmacies for specific patients when an FDA-approved version isn't available or doesn't meet a patient's needs. Compounding has a legitimate medical purpose. But compounded GLP-1s are not the same as Wegovy pill or Foundayo. Specifically:
- They are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before they reach patients.
- The active ingredient may not be at the same concentration as the brand drug.
- The FDA states that semaglutide and tirzepatide do not currently appear on the FDA drug shortage list or the 503B bulks list. The shortage-based enforcement-discretion periods that allowed wide-scale compounding have ended.
- The FDA has reported concerns about unapproved GLP-1 products, including dosing errors, salt forms, fraudulent products, and adverse events.
OTC “GLP-1 supplements” and “GLP-1 boosters”
These are not GLP-1 medicine. They're supplements that claim to support natural GLP-1 production. The giveaways:
- "Available without a prescription"
- "All-natural" or "plant-based" GLP-1
- Claims of weight loss matching prescription medications
- Sold on Amazon, TikTok Shop, Instagram ads
Side Effects, Risks, and Who Should Not Take a GLP-1 Pill
The most common side effects of both the Wegovy pill and Foundayo are gastrointestinal — nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, and headache. Most are mild to moderate and most prominent during dose escalation. Both medications carry a boxed warning for thyroid C-cell tumors.
Common side effects (>5% of patients)
- Nausea, diarrhea, vomiting, constipation
- Abdominal pain, indigestion (dyspepsia)
- Headache, fatigue
- Belching, heartburn (GERD), gas
- Hair loss (specifically listed in Foundayo’s label)
- Abdominal distention
Most GI symptoms ease within a few weeks at each dose level.
Discontinuation rates from FDA labels
| Medication | Stopped (AE) | Placebo |
|---|---|---|
| Wegovy pill (OASIS 4) | 6.9% | 5.9% |
| Wegovy pill — GI specifically | 3.4% | 2% |
| Foundayo (overall, all doses) | 8% | 3% |
| Foundayo 5.5 mg | ~6% | — |
| Foundayo 9 mg | ~9% | — |
| Foundayo 17.2 mg | ~10% | — |
Serious risks (boxed warning + warnings/precautions)
True contraindications (do not use)
- Personal or family history of medullary thyroid carcinoma
- Multiple Endocrine Neoplasia syndrome type 2
- Serious hypersensitivity to the medication or any of its ingredients
Needs extra clinician review
- Severe gastroparesis or active inflammatory bowel disease
- History of pancreatitis
- Active gallbladder disease
- Kidney disease or dehydration risk
- Diabetic retinopathy
- Pregnancy or planning pregnancy
- Breastfeeding
- Currently taking another GLP-1 receptor agonist
- Combined oral contraceptive users on Foundayo
- Complex oral medication regimens
How Long Until You See Results?
Both pills require gradual dose escalation over the first 3–6 months before you reach the maintenance dose where most weight loss occurs. The headline trial results represent the full study period — 64 weeks for the Wegovy pill and 72 weeks for Foundayo. Plan for the long term.
What happens if you stop?
Most patients regain weight when they stop the medication. The STEP 4 trial of injectable semaglutide showed average regain of about 6.9% body weight in the year after discontinuation. Translation: GLP-1 medication is a long-term tool, like a medication for blood pressure or cholesterol. It's not a 12-week reset. This isn't a reason not to start — it's a reason to plan: budget for the long term, build the lifestyle changes that go with the medication (calorie-aware eating, strength training, protein intake), and have a real conversation with your prescriber about what stopping eventually looks like.
How to Get a GLP-1 Pill Prescribed Online (Step by Step)
The fastest path: start a Ro Body consult, complete the medical intake, get evaluated by a licensed clinician, and have the prescription routed to your insurance pharmacy or a partner pharmacy.
- 1
Run insurance first (60 seconds, free)
Use Ro’s free GLP-1 Insurance Coverage Checker. You’ll know whether your plan covers Wegovy pill or Foundayo. This is the highest-leverage move and costs nothing.
- 2
Start your Ro Body consult
Complete the medical intake — your weight history, current medications, medical conditions, weight goals. Pay the Ro Body membership: $39 first month, then as low as $74/month with annual prepay or $149/month monthly.
- 3
Provider review
A licensed clinician reviews your case. They prescribe what they think fits your situation, or they tell you a pill isn’t medically appropriate and route you to alternatives. You can request a specific pill if you have a preference — the prescriber decides what’s clinically appropriate.
- 4
Pharmacy fulfillment
If insurance covers your pill, the prescription goes to your insurance pharmacy. If you’re paying cash, it routes to NovoCare Pharmacy (Wegovy pill) or LillyDirect’s affiliated pharmacy (Foundayo). Cold-chain shipping isn’t required for pills (unlike injectable Wegovy).
- 5
First fill ships
You’ll get tracking once the pharmacy fills the prescription. Pills don’t require special cold storage.
- 6
Ongoing care
Your provider monitors progress monthly. Dose escalation, side effects, switching medications — all handled through the platform without restarting the consult.
What to verify before submitting payment
- Which medication is being prescribed (FDA-approved or compounded)
- Dose-level price for the medication, not just the starter price
- Total monthly cost (medication + program fee)
- Cancellation policy
- Which pharmacy fills it
- Whether your insurance applies
- Any government-plan exclusions (Medicare, Medicaid, Tricare are typically excluded from manufacturer savings offers)
Decision Resolution Point #7
Ready to start? A licensed clinician reviews your intake and confirms whether a GLP-1 pill is clinically appropriate for you.
Begin your Ro Body consult → (sponsored affiliate link, opens in a new tab)Frequently Asked Questions
- What is the best GLP-1 pill for weight loss in 2026?
- The Wegovy pill produces the highest mean weight loss in clinical trials (13.6%–16.6%) and is the only oral GLP-1 with an FDA cardiovascular protection label. Foundayo is the better fit for adults who can’t reliably fast for 30 minutes every morning, since it has no food, water, or timing restrictions. Both are FDA-approved and start at $149 per month cash. The “best” depends on your lifestyle, insurance, and medical history.
- Is there a GLP-1 pill for weight loss?
- Yes. As of May 2026, two GLP-1 pills are FDA-approved for chronic weight management: the Wegovy pill (oral semaglutide 25 mg, approved December 2025) and Foundayo (orforglipron, approved April 2026). Rybelsus is also a GLP-1 pill but is FDA-approved only for type 2 diabetes.
- Is the Wegovy pill the same as the Wegovy injection?
- Both contain the same active ingredient — semaglutide — but the pill is once daily and the injection is once weekly. The injection produced about 15% mean weight loss in trials; the pill produced 13.6%–16.6%. Both have the FDA cardiovascular outcomes label. The pill must be taken on an empty stomach with no food for 30 minutes after; the injection has no such restriction.
- Can I take Rybelsus for weight loss?
- Rybelsus is FDA-approved only for type 2 diabetes. A clinician can prescribe it off-label for weight loss, but it’s typically not the first choice — the dose ceiling is 14 mg (vs 25 mg for the Wegovy pill) and weight loss in non-diabetic patients has been modest in studies.
- How much does a GLP-1 pill cost per month?
- Cash price on Ro starts at $149 per month for the lowest dose of either Wegovy pill or Foundayo and rises to $299 per month at the maintenance doses. With eligible commercial insurance and the manufacturer savings offer, both can drop to as low as $25 per month. A Wegovy 12-month subscription locks the high doses (9 mg and 25 mg) at $249 per month for cash-paying patients.
- Does insurance cover GLP-1 pills?
- Coverage varies by plan, and Foundayo coverage is still rolling out across plans in 2026. Many commercial insurance plans cover Wegovy pill for FDA-approved weight loss indications when the patient meets BMI criteria. Medicare currently does not cover either pill for weight loss alone. Ro’s free Insurance Coverage Checker tells you in 60 seconds whether your plan covers either pill.
- Are GLP-1 pills as effective as the shots?
- Slightly less effective on average. The Wegovy pill produces 13.6%–16.6% mean weight loss vs about 15% for the Wegovy injection. Foundayo produces 11.1%–12.4% vs about 21% for Zepbound (tirzepatide injection). The gap is real but not enormous. For most patients, taking the medication consistently every day matters at least as much as a 2–5 percentage point efficacy difference.
- Can I take a GLP-1 pill if I'm not diabetic?
- Yes. Both Wegovy pill and Foundayo are approved for adults with obesity (BMI 30+) or overweight (BMI 27+) plus at least one weight-related condition like high blood pressure, high cholesterol, sleep apnea, or cardiovascular disease. You don’t need to have type 2 diabetes to qualify.
- Where can I get a GLP-1 pill prescribed online?
- Both pills are available through Ro, Sesame Care, Hims, Hers, LifeMD, WeightWatchers, NovoCare Pharmacy (Wegovy pill direct), LillyDirect (Foundayo direct), and at retail pharmacies including CVS and Costco. Ro is our editor’s pick because it carries both pills, posts dose-level pricing, and includes a free insurance concierge.
- Will I gain the weight back if I stop?
- Most patients regain a meaningful amount of weight when they stop GLP-1 therapy. The STEP 4 trial of injectable semaglutide showed average regain of about 6.9% body weight in the year after discontinuation. GLP-1 medications are typically used long-term, similar to medications for blood pressure or cholesterol.
- What are the side effects of a GLP-1 pill?
- The most common side effects of both pills are gastrointestinal: nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, and headache. Most are mild to moderate and resolve within a few weeks of dose escalation. Both drugs carry a boxed warning for thyroid C-cell tumors and are contraindicated in patients with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia type 2.
- Are compounded oral GLP-1 drops the same as FDA-approved pills?
- No. Compounded oral GLP-1 drops, lozenges, or custom formulations are not FDA-approved and are not reviewed for safety, effectiveness, or quality before they reach patients. FDA-approved pills (Wegovy pill, Foundayo) are different products with established trial data and FDA oversight.
- Are OTC “GLP-1 supplements” the same as prescription GLP-1 pills?
- No. OTC “GLP-1 booster” supplements are not prescription GLP-1 medications and do not have the same FDA-reviewed weight management approval, label, or trial evidence as Wegovy pill or Foundayo.
- Foundayo vs Wegovy pill — which is cheaper?
- Both start at $149 per month for the lowest dose with cash pricing on Ro, and both can drop to as low as $25 per month with eligible commercial insurance and the manufacturer savings offer. The Wegovy pill’s maintenance doses are $299 per month; Foundayo’s high doses are $299 per month with the manufacturer offer (refill within 45 days) or $349 per month without. Wegovy offers a 12-month subscription at $249 per month for the 9 mg and 25 mg doses; Foundayo doesn’t yet.
- What should I ask before starting?
- Ask which medication is being prescribed, whether it’s FDA-approved or compounded, what the dose-escalation plan looks like, what your long-term cost will be (not just the starter price), what side effects to watch for, and who monitors your care between visits.
What We Actually Verified
| What we verified | Source | Verified date |
|---|---|---|
| Wegovy pill FDA approval (Dec 22, 2025) | FDA press release; Novo Nordisk press release | May 8, 2026 |
| Foundayo FDA approval (April 1, 2026) | FDA press release; Eli Lilly press release | May 8, 2026 |
| OASIS 4 trial efficacy data | NEJM publication; Novo Nordisk OASIS 4 results | May 8, 2026 |
| ATTAIN-1 trial efficacy data | Eli Lilly press release April 1, 2026; Foundayo prescribing label | May 8, 2026 |
| Wegovy pill prescribing info (titration, restrictions, contraindications, boxed warning, discontinuation rates) | FDA prescribing label, accessdata.fda.gov | May 8, 2026 |
| Foundayo prescribing info | FDA prescribing label, accessdata.fda.gov | May 8, 2026 |
| Wegovy pill cash pricing | NovoCare pharmacy; Ro pricing page | May 8, 2026 |
| Foundayo cash pricing and 45-day refill terms | LillyDirect; Ro pricing page | May 8, 2026 |
| Wegovy 12-month subscription terms (9 mg + 25 mg pill; up to $600/year savings) | Novo Nordisk press release April 1, 2026 | May 8, 2026 |
| Ro Body membership pricing | ro.co/weight-loss/pricing | May 8, 2026 |
| Ro, Sesame, Hims, Hers, LifeMD, WW formulary for both pills | Provider pages and press releases | May 8, 2026 |
| FDA guidance on unapproved compounded GLP-1 drugs | fda.gov/drugs/postmarket-drug-safety-information | May 8, 2026 |
| FDA semaglutide / tirzepatide shortage status (resolved) | FDA shortage clarification | May 8, 2026 |
How we ranked the options
| Criterion | Weight |
|---|---|
| FDA approval for adult weight management | 25 |
| Practical daily routine and adherence | 20 |
| Transparent dose-level pricing | 20 |
| Online access and insurance support | 15 |
| Evidence maturity and label clarity | 15 |
| Regulatory clarity (no compounded confusion) | 5 |
How we make money: The RX Index is a free reader resource funded by affiliate commissions when readers click through and start a consult with a partner provider. Ro and Sesame Care are our largest partners. We do not change recommendations based on commission rate.
Final Recommendation
For most adults with eligible commercial insurance, the Wegovy pill on Ro is our pick. Highest weight loss in trials, FDA cardiovascular protection label, and as low as $25 a month with the manufacturer savings offer when your plan covers the medication. The strict morning routine is the cost of admission — if you can do it, the data is on your side.
For adults whose mornings are chaotic or who simply want the simplest daily pill, Foundayo on Ro is the pick. No fasting, no timing rules, slightly less weight loss in trials but the simplest GLP-1 pill schedule on the market.
For adults who genuinely can't access either pill, insurance appeal is the right first move. Ro's concierge handles it for free. Patient assistance programs exist.
Free coverage check. 5-minute consult. With eligible commercial insurance and the manufacturer savings offer, you may pay as low as $25/month.